Allstate (NYSE:ALL) Price Target Raised to $225.00

Allstate (NYSE:ALL) had its target price upped by UBS Group from $216.00 to $225.00 in a research note issued to investors on Monday morning, Benzinga reports. UBS Group currently has a buy rating on the insurance provider’s stock.

ALL has been the topic of several other reports. Jefferies Financial Group upped their price target on Allstate from $217.00 to $231.00 and gave the company a “buy” rating in a research report on Wednesday, October 9th. Evercore ISI upped their target price on shares of Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a report on Wednesday, October 9th. Barclays increased their target price on shares of Allstate from $175.00 to $187.00 and gave the stock an “underweight” rating in a research note on Thursday, October 31st. StockNews.com lowered shares of Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. Finally, BMO Capital Markets increased their price objective on Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $209.50.

Allstate Stock Up 2.0 %

ALL opened at $188.69 on Monday. The company has a 50 day moving average of $188.89 and a 200 day moving average of $175.59. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. Allstate has a 12 month low of $127.93 and a 12 month high of $198.79. The company has a market cap of $49.97 billion, a PE ratio of 12.22, a price-to-earnings-growth ratio of 1.73 and a beta of 0.48.

Allstate (NYSE:ALL) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. During the same period last year, the company earned $0.81 earnings per share. The business’s revenue for the quarter was up 14.7% on a year-over-year basis. On average, sell-side analysts expect that Allstate will post 15.23 EPS for the current year.

Insider Transactions at Allstate

In related news, EVP Robert Toohey sold 16,682 shares of Allstate stock in a transaction on Monday, August 19th. The shares were sold at an average price of $180.17, for a total value of $3,005,595.94. Following the transaction, the executive vice president now owns 4,873 shares in the company, valued at $877,968.41. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the sale, the chief executive officer now owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Toohey sold 16,682 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the completion of the transaction, the executive vice president now owns 4,873 shares in the company, valued at $877,968.41. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 192,530 shares of company stock worth $34,967,665. 1.80% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Allstate

Institutional investors have recently added to or reduced their stakes in the company. Northwest Investment Counselors LLC bought a new position in shares of Allstate during the third quarter valued at about $28,000. Catalyst Capital Advisors LLC bought a new position in Allstate during the 3rd quarter valued at approximately $29,000. Versant Capital Management Inc lifted its holdings in Allstate by 70.9% in the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after buying an additional 78 shares during the period. Family Firm Inc. bought a new stake in shares of Allstate in the 2nd quarter worth approximately $38,000. Finally, MCF Advisors LLC increased its stake in shares of Allstate by 33.9% during the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after buying an additional 84 shares during the period. Hedge funds and other institutional investors own 76.47% of the company’s stock.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.